Atlas Trials

Multiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease Subjects

Clinical trial NCT01258205 · COMPLETED

Trial details

NCT number
NCT01258205
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Crohn's Disease
Start date
2011-02-28
Primary completion
2015-02-18
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.